Prognostic markers of low-grade squamous intraepithelial lesions: The role of topoisomerase IIα and active caspase-3

European Journal of Gynaecological Oncology

Volumn 29, Issue 5, 2008, Pages 499-501

  Coelho, R A ^a,b   Focchi, G R A ^a   Nogueira de Souza, N C ^a   Sartori, M G F ^a   Silva, I D C G ^a   Ribalta, J C L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Caspase 3; HPV; Neoplasia; Topoisomerase II alpha

Indexed keywords

CASPASE 3; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CASPASE 3; DISEASE PROGRESSION; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 54949128973     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S. et al.: "Prevalence of HPV infection among females in the United States". JAMA, 2007, 297, 813.
2. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A. et al.: "Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia". JAMA, 2001, 286, 3106.
3. von Knebel Doeberitz M.: "New markers for cervical dysplasia to visualize the genomic chaos created by aberrant oncogenic papillomavirus infections". Eur. J. Cancer, 2002, 38, 2229.
4. Hsiang T.S.: "DNA topoisomerases". Curr. Opin. Cell. Biol., 1992, 4, 396.
5. McLeod H.L., Douglas F., Oates M., Syrmonds R.P., Prakash D., Van Der Zee A.G.J. et al.: "Topoisomerase I and II activity in human breast, cervix, lung and colon cancer". Int. J. Cancer, 1994, 59, 607.
6. Walker F., Adle-Biassette H., Madelenat P., Hénin D., Lehy T.: "Increased apoptosis in cervical intraepithelial neoplasia associated with HIV infection: implication of oncogenic human papillomavirus, caspases, and Langerhans cells". Clin. Cancer Res., 2005, 11, 2451.
7. Horta M.F., Young J.D.: "Quando a célula programa a própria morte". Ci Hoje., 1999, 25, 38.
8. El-Mahdy M.A., Zhu Q., Wang Q.E., Wani G., Wani A.A.: "Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells". Int. J. Cancer, 2005, 117, 409.
9. Thornberry N.A., Lazebnik Y.: "Caspases: enemies within". Science, 1998, 281, 1312.
10. Liang Y., Yan C., Schor N.F.: "Apoptosis in the absensce of caspase 3". Oncogene, 2001, 20, 6570.
11. Hafian H., Venteo L., Sukhanova A., Nabiev I., Lefevre B., Pluot M.: "Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53. and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas". Hum. Pathol., 2004, 35, 745.
12. Villa L.L., Franco E.L.F: "Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil". J. Natl. Cancer Inst., 1989, 81, 332.
13. Duttagupta C., Basu J., Ray M., Romney S.L.: "Apoptotic changes in cervical intraepithelial neoplasia". Gynecol. Obstet. Invest., 2001, 52, 38.
14. Grce M., Husnjak K., Bozikov J., Magdic L., Zlacki M., Lukac J., et al.: "Evaluation of genital human papillomavirus infections by polymerase chain reaction among Croatian women". Anticancer Res., 2001, 21, 579.
15. Camara G.N., Cerqueira D.M., Oliveira A.P., Silva E.O., Carvalho L.G., Martins C.R.: "Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil". Mem. Inst. Oswaldo Cruz., 2003, 98, 879.
16. Kulmala S.M., Syrjanen S., Shabalova I., Petrovichev N., Kozachenzo V., Podistov J. et al.: "Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tool". J. Clin. Microbiol., 2004, 42, 2470.
17. Da Silva T.T., Guimarães M.L., Barbosa M.I.C., Pinheiro M.F.G., Maia A.F.: "Identificação de tipos de papilomavírus e de outros fatores de risco para neoplasia intra-epitelial cervical". Rev. Bras. Ginecol. Obstet., 2006, 28, 285.
18. Yokoyama M., Iwasaka T., Nagata C., Nozawa S., Sekiya S., Hirai Y. et al.: "Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan". Cancer Lett., 2003, 192, 171.
19. Burger M.P., Hollema H., Pieters W.J., Schroder F.P., Quint W.G.: "Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus". Br. J. Cancer, 1996, 73, 831.
20. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C. et al.: "The carcinogenicity of human papillomavirus types reflects viral evolution". Virology, 2005, 337, 76.